Acute Declines in Estimated GFR in Blood Pressure Target Trials and Risk of Adverse Outcomes. Ku E, McCulloch CE, Copeland TP, Inker LA, et al. Am J Kidney Dis 2023;82:454-463.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ku E, McCulloch CE, Copeland TP, Inker LA, et al. Acute Declines in Estimated GFR in Blood Pressure Target Trials and Risk of Adverse Outcomes. Am J Kidney Dis 2023;82:454-463.
PMID: 37269972